133 related articles for article (PubMed ID: 32787271)
21. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
Fukuiwa T; Sekine S; Kobayashi R; Suzuki H; Kataoka K; Gilbert RS; Kurono Y; Boyaka PN; Krieg AM; McGhee JR; Fujihashi K
Vaccine; 2008 Sep; 26(37):4849-59. PubMed ID: 18625280
[TBL] [Abstract][Full Text] [Related]
22. Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity.
Liu J; Yan XD; Li XQ; Du YH; Zhu LL; Ye TT; Cao ZY; Dong ZW; Li ST; Xu X; Bai W; Li D; Zhang JW; Wang SJ; Li SH; Sun J; Yin XZ
Front Immunol; 2023; 14():1132129. PubMed ID: 36845130
[TBL] [Abstract][Full Text] [Related]
23. Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses.
Fu W; Guo M; Zhou X; Wang Z; Sun J; An Y; Guan T; Hu M; Li J; Chen Z; Ye J; Gao X; Gao GF; Dai L; Wang Y; Chen C
ACS Nano; 2024 Apr; 18(17):11200-11216. PubMed ID: 38620102
[TBL] [Abstract][Full Text] [Related]
24. Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.
Smith A; Perelman M; Hinchcliffe M
Hum Vaccin Immunother; 2014; 10(3):797-807. PubMed ID: 24346613
[TBL] [Abstract][Full Text] [Related]
25. Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site.
Sasaki E; Asanuma H; Momose H; Furuhata K; Mizukami T; Matsumura T; Takahashi Y; Hamaguchi I
Mucosal Immunol; 2023 Jun; 16(3):275-286. PubMed ID: 36935091
[TBL] [Abstract][Full Text] [Related]
26. Mucosal Immunization with Spore-Based Vaccines against
Uddin MS; Kaldis A; Menassa R; Ortiz Guluarte J; Barreda DR; Guan LL; Alexander TW
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675757
[TBL] [Abstract][Full Text] [Related]
27. Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses.
Li GC; Li HF; Jin Z; Feng R; Deng Y; Cheng H; Li HB
J Vis Exp; 2024 Feb; (204):. PubMed ID: 38465928
[TBL] [Abstract][Full Text] [Related]
28. Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
Laura Soriano Pérez M; Montironi I; Alejandro Funes J; Margineda C; Campra N; Noelia Cariddi L; José Garrido J; Molina M; Alustiza F
Vaccine; 2024 Jun; 42(17):3721-3732. PubMed ID: 38719694
[TBL] [Abstract][Full Text] [Related]
29. Autoclave-Induced Changes in the Physicochemical Properties and Antigen Adsorption of Aluminum Adjuvants.
Yu G; Yang W; Zhang N; Yang C; Zeng H; Xue C; Sun B
J Pharm Sci; 2024 Feb; 113(2):455-462. PubMed ID: 37813301
[TBL] [Abstract][Full Text] [Related]
30. A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect.
Luo X; Song Z; Zeng X; Ye Y; Zheng H; Cai D; Yuan Q; Li H; Tong Y; Lu D; Liu Y; Zeng H; Yang Y; Sun H; Zou Q
Front Immunol; 2023; 14():1154836. PubMed ID: 37415983
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice.
Johnston D; Reynolds SR; Bystryn JC
Cancer Immunol Immunother; 2006 Apr; 55(4):412-9. PubMed ID: 16151809
[TBL] [Abstract][Full Text] [Related]
32. Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits.
Staats HF; Fielhauer JR; Thompson AL; Tripp AA; Sobel AE; Maddaloni M; Abraham SN; Pascual DW
PLoS One; 2011 Jan; 6(1):e16532. PubMed ID: 21304600
[TBL] [Abstract][Full Text] [Related]
33. Toward precision adjuvants: optimizing science and safety.
Nanishi E; Dowling DJ; Levy O
Curr Opin Pediatr; 2020 Feb; 32(1):125-138. PubMed ID: 31904601
[TBL] [Abstract][Full Text] [Related]
34. Vaccine delivery alerts innate immune systems for more immunogenic vaccination.
Li Z; Cao Y; Li Y; Zhao Y; Chen X
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33690222
[TBL] [Abstract][Full Text] [Related]
35. Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles.
Thakkar SG; Xu H; Li X; Cui Z
J Drug Target; 2018; 26(5-6):474-480. PubMed ID: 29334279
[TBL] [Abstract][Full Text] [Related]
36. Novel adjuvants and vaccine delivery systems.
Morein B; Villacrés-Eriksson M; Sjölander A; Bengtsson KL
Vet Immunol Immunopathol; 1996 Nov; 54(1-4):373-84. PubMed ID: 8988882
[TBL] [Abstract][Full Text] [Related]
37. Solidified saturated fats coating subunit vaccines greatly extended vaccine booster release and contributed to a Th1/Th2 mixed immune response in mice.
Choudhary P; Boamah B; Hon Ng S; White A; Weber LP; Wilson HL
Vaccine; 2023 Jun; 41(27):3989-4001. PubMed ID: 37230887
[TBL] [Abstract][Full Text] [Related]
38. Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model.
Shaw HA; Remmington A; McKenzie G; Winkel C; Mawas F
Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006056
[TBL] [Abstract][Full Text] [Related]
39. Manganese salts function as potent adjuvants.
Zhang R; Wang C; Guan Y; Wei X; Sha M; Yi M; Jing M; Lv M; Guo W; Xu J; Wan Y; Jia XM; Jiang Z
Cell Mol Immunol; 2021 May; 18(5):1222-1234. PubMed ID: 33767434
[TBL] [Abstract][Full Text] [Related]
40. Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission.
Russell MW; Mestecky J
Front Immunol; 2022; 13():957107. PubMed ID: 36059541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
